High bile acids in dogs signal that the liver is not processing blood from the gut the way it should, and treatment depends entirely on what is driving the problem. Elevated serum bile acids are not a disease in themselves but a red flag pointing toward conditions like portosystemic shunts, chronic hepatitis, or copper storage disease. Because the underlying cause dictates the approach, a veterinarian’s first job is figuring out why bile acids are high before choosing a treatment plan. That plan can range from dietary changes and oral medications to major surgery, and many dogs do well once the right combination is in place.
Why Bile Acids Rise in the First Place
Bile acids are produced by the liver, stored in the gallbladder, and released into the intestines to help digest fat. After they do their job, they are reabsorbed in the lower intestine and carried back to the liver through the portal vein, where the liver recycles them. When the liver is damaged or when blood bypasses it entirely, those recycled bile acids spill into the general circulation and show up at abnormally high levels on a blood test.
The most common reasons for persistently elevated bile acids in dogs fall into a few broad categories. Portosystemic shunts, either congenital or acquired, are one of the biggest culprits. In dogs with a portosystemic shunt, blood from the intestines flows through an abnormal vessel that skips past the liver entirely and dumps directly into systemic circulation.1Medycyna Weterynaryjna. Gastrointestinal ulceration in dogs with portosystemic shunt The liver never gets a chance to clear the bile acids, so they accumulate. Chronic hepatitis, whether immune-mediated or caused by copper accumulation, is another frequent cause. Less commonly, gallbladder disease, certain toxins, or diffuse liver tumors can produce the same pattern.
The treatment path splits sharply depending on which of these conditions is responsible. A dog with a congenital shunt may ultimately need surgery, while a dog with immune-mediated hepatitis needs immunosuppressive drugs. Getting the diagnosis right is the step that matters most.
Medical Management With Ursodeoxycholic Acid and Hepatoprotectants
Ursodeoxycholic acid, often called UDCA or by the brand name Actigall, is one of the most widely used medications for dogs with liver disease and elevated bile acids. UDCA is itself a bile acid, but a gentler one. It works by displacing more toxic bile acids that accumulate when liver function is impaired, and it also has anti-inflammatory and cell-protective properties in liver tissue.
Research on dogs with hepatic dysfunction has shown that UDCA improves biochemical markers on its own and performs even better when paired with other supplements. One study compared UDCA alone against UDCA combined with silymarin (the active compound in milk thistle) and UDCA combined with L-ornithine L-aspartate, a supplement that helps the body process ammonia. After three weeks of treatment, the combination of UDCA and L-ornithine L-aspartate was the most effective at improving liver values, followed by the UDCA-silymarin combination, with UDCA alone being the least effective of the three treatment arms.2Academia. Therapeutic Efficacy of Different Drugs Combined with Ursodeoxycholic Acid for Canine Hepatic Dysfunction
Silybin, the most bioactive component of silymarin, has been studied on its own as a hepatoprotectant in dogs. In a trial of dogs with liver disease, supplementation with a commercial silybin-containing product led to decreased activity of liver enzymes like ALT and AST, along with drops in liver-specific microRNA markers, indicating reduced liver cell damage.3BioMed Central / BMC Veterinary Research. Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs These results support the use of silybin as a practical add-on for dogs with ongoing liver problems.
S-adenosylmethionine, commonly known as SAMe, is another supplement frequently prescribed alongside UDCA. SAMe serves as a precursor for glutathione, one of the liver’s main internal antioxidants. When liver cells are under stress, glutathione gets depleted, and SAMe supplementation helps replenish it. Vitamin E is also used to combat oxidant damage in the liver.4PubMed Central. Current concepts in the treatment of canine chronic hepatitis Many veterinarians prescribe a cocktail of UDCA, SAMe, and silybin together as a baseline liver-support regimen, regardless of the specific diagnosis.
Treating the Underlying Liver Disease
Hepatoprotectants address the symptoms and shield the liver from further damage, but they do not fix the root cause. When chronic hepatitis is driving the elevated bile acids, treatment aimed at the disease itself is essential.
Immune-Mediated Chronic Hepatitis
In many dogs, chronic hepatitis is driven by the immune system attacking liver tissue. Treatment for this type centers on immunosuppression. Cyclosporine, mycophenolate, and corticosteroids like prednisone are the main options, and the choice among them depends on the severity of disease and the dog’s tolerance for side effects.5PubMed. Immune-Mediated Chronic Hepatitis in Dogs Corticosteroids work quickly but carry well-known downsides with long-term use, including increased thirst, weight gain, and muscle wasting. Cyclosporine is often used as a steroid-sparing alternative, and it has shown encouraging results. In one retrospective study, a treatment regimen that included cyclosporine along with frequent hepatoprotectant use achieved biochemical remission in most dogs with idiopathic chronic hepatitis.6PubMed Central. Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs
The prognosis for immune-mediated chronic hepatitis is generally good to excellent, but outcomes are better when treatment starts early, before extensive fibrosis or cirrhosis has developed.7PubMed. Immune-Mediated Chronic Hepatitis in Dogs This is one reason veterinarians push for liver biopsies rather than treating empirically: knowing whether the hepatitis is immune-mediated changes the entire treatment strategy and makes earlier intervention possible.
Copper-Associated Hepatitis
Some breeds, particularly Labrador Retrievers, Bedlington Terriers, and Doberman Pinschers, are prone to accumulating excess copper in their liver cells. The copper itself causes inflammation and progressive liver damage, which in turn raises bile acids. Treatment for copper-associated hepatitis aims to create a negative copper balance in the body, meaning the dog excretes more copper than it takes in. The most commonly used drug for this is D-penicillamine, a metal chelator that binds copper and promotes its excretion through the kidneys.8PubMed. Nutritional management of inherited copper-associated hepatitis in the Labrador retriever
D-penicillamine has been shown to effectively reduce hepatic copper concentrations and the associated inflammatory lesions in Labrador Retrievers.9PubMed. D-penicillamine treatment of copper-associated hepatitis in Labrador retrievers Dietary management plays a supporting role here: feeding a low-copper diet and, in some cases, supplementing with zinc to block copper absorption from the gut. Zinc works by inducing a protein in the intestinal lining that traps copper and prevents it from entering the bloodstream. This dietary approach complements the chelation therapy and helps maintain lower copper levels long-term.10PubMed. Nutritional management of inherited copper-associated hepatitis in the Labrador retriever
Managing Dogs With Portosystemic Shunts
For dogs whose elevated bile acids stem from a portosystemic shunt, the treatment conversation looks very different. The abnormal vessel allowing blood to bypass the liver is a structural problem, and while medical management can control symptoms, surgery is usually the definitive fix for congenital extrahepatic shunts.
Pre-Surgical Medical Stabilization
Before surgery, and sometimes indefinitely for dogs who are not surgical candidates, medical management focuses on controlling the toxic effects of portal blood reaching the brain and body without being filtered by the liver. The biggest concern is hepatic encephalopathy, a condition in which ammonia and other toxins that the liver normally clears build up and cause neurological symptoms like disorientation, head pressing, seizures, or circling.
The standard approach combines a hepatic support diet (moderate, high-quality protein to reduce ammonia production in the gut) with lactulose, a synthetic sugar that acidifies the colon and traps ammonia so it gets excreted in the stool rather than absorbed. A study comparing different pre-surgical treatment combinations in dogs with congenital extrahepatic shunts found that the combination of a hepatic support diet plus lactulose significantly reduced clinical scores, while the diet alone did not. Adding metronidazole, an antibiotic sometimes used to reduce ammonia-producing bacteria in the gut, did not produce further improvement beyond what lactulose had already achieved.11Wiley Online Library / Journal of Veterinary Internal Medicine. Comparison of diet, lactulose, and metronidazole combinations in the control of pre‐surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts That finding is useful because metronidazole can cause neurological side effects of its own, and knowing it does not add much benefit to a lactulose-based protocol gives veterinarians reason to keep things simpler.
Surgical Correction
Surgery for congenital extrahepatic portosystemic shunts typically involves placing a device around the abnormal vessel that gradually closes it off, forcing blood to flow through the liver as it should. Two devices are commonly used: ameroid ring constrictors and cellophane bands (sometimes called thin film banding). Both work on the principle of slow occlusion. The ameroid ring absorbs body fluid and swells, slowly compressing the shunt vessel. Cellophane banding triggers a controlled inflammatory response around the vessel that causes it to scar closed over weeks.
Outcomes with both devices are generally favorable. A study comparing ameroid ring constrictors and cellophane bands in 49 dogs found both methods effective, with good to excellent outcomes and low rates of complications and death.12PubMed. Comparative outcomes between ameroid ring constrictor and cellophane banding for treatment of single congenital extrahepatic portosystemic shunts in 49 dogs (1998-2012) Another study looking at long-term survival after ameroid ring constrictor placement found that dogs generally had a good prognosis with prolonged survival after surgery.13PubMed. Long-term outcome after surgical ameroid ring constrictor placement for treatment of single extrahepatic portosystemic shunts in dogs One comparison did note that persistent shunting requiring a second surgery was more common with thin film banding than with ameroid constrictors, though both approaches achieved good long-term outcomes overall.14PubMed. Outcomes of dogs treated for extrahepatic congenital portosystemic shunts with thin film banding or ameroid ring constrictor
It is worth knowing that surgery does not always normalize bile acid levels completely. A study tracking bile acid concentrations long-term in 51 dogs after complete shunt ligation found that while pre- and post-meal bile acids dropped significantly compared to pre-operative levels, they remained higher than those of healthy control dogs at all follow-up points.15Wiley Online Library / Journal of Small Animal Practice. Long-term serum bile acid concentrations in 51 dogs after complete extrahepatic congenital portosystemic shunt ligation Clinically, most of these dogs did fine despite the lingering elevation. This is important context for owners who may be anxious about a post-surgical bile acid test that still reads “abnormal” on paper.
When Bile Acid Diarrhea Is the Problem
Not every case of high bile acids involves the liver directly. Some dogs develop bile acid diarrhea, a condition in which excess bile acids reach the colon and cause chronic watery stool. This can happen after intestinal surgery, with certain types of intestinal disease, or sometimes without an identifiable cause. In these dogs, a bile acid sequestrant called cholestyramine has shown promise. Cholestyramine is an oral resin that binds bile acids in the gut and prevents them from irritating the colon. A case report described two dogs with presumed bile acid diarrhea who were treated with cholestyramine and showed marked improvement in stool consistency, frequency of defecation, and overall activity level.16Europe PMC. Cholestyramine treatment in two dogs with presumptive bile acid diarrhoea: a case report While this is limited evidence, cholestyramine is well established in human medicine for the same purpose, and veterinarians are increasingly considering it when chronic diarrhea does not respond to the usual dietary and antibiotic approaches.
The Role of Diet
Dietary management is a supporting pillar in nearly every scenario that produces elevated bile acids. The specifics vary by condition. For dogs with portosystemic shunts or hepatic encephalopathy, the emphasis is on feeding moderate amounts of high-quality, highly digestible protein. The goal is to provide enough protein to maintain muscle and body condition without overloading the gut bacteria that produce ammonia as a byproduct of protein digestion. Commercial hepatic diets are formulated for this balance. Soy-based and dairy-based proteins tend to generate less ammonia than meat-based proteins, so some hepatic diets lean on those sources.
For dogs with copper-associated hepatitis, diet takes a more specific form. Copper content in commercial dog food varies widely, and some foods contain far more copper than a susceptible dog can safely handle. Feeding a low-copper diet and avoiding ingredients like organ meats, which are naturally high in copper, is part of the long-term management plan. Zinc supplementation may also be included because zinc competes with copper for absorption.
For dogs with chronic hepatitis from other causes, antioxidant support through diet matters. Vitamin E supplementation is commonly recommended to help protect liver cells from oxidative stress.17PubMed Central. Current concepts in the treatment of canine chronic hepatitis Some owners gravitate toward home-cooked diets to gain more control over ingredients, but it is critical to work with a veterinary nutritionist in these cases. A well-intentioned homemade liver diet can easily become unbalanced in ways that make things worse.
Monitoring Treatment Over Time
Once treatment starts, periodic bile acid testing is one of the main tools veterinarians use to track progress. A fasting bile acid level is measured before a meal, then a post-meal level is drawn two hours after eating. Both numbers matter, and the post-meal value is often the more sensitive indicator of liver function. In healthy dogs, post-meal bile acids stay within a well-defined range, and the test is reliable enough to be a useful diagnostic and monitoring tool.18PubMed. Serum bile acids: reference values in healthy dogs and comparison of two kit methods
For dogs on medical management for chronic hepatitis, veterinarians typically recheck liver enzymes and bile acids every few weeks to months during the initial phase, then extend the interval once the dog is stable. Liver biopsies may be repeated periodically to assess whether inflammation and fibrosis are actually improving at the tissue level, since blood tests do not always tell the full story.
For dogs post-shunt surgery, bile acid levels are usually rechecked at set intervals to confirm the shunt is closing. As noted earlier, levels may remain modestly elevated even after successful surgery, so veterinarians look for the trend and the dog’s clinical improvement rather than fixating on a single number.
Emerging Biomarkers and Early Detection
One limitation of standard liver tests, including bile acids, is that they can sometimes miss early or low-grade liver damage. ALT, the enzyme most commonly used to screen for liver cell injury, does not always rise in dogs with chronic hepatitis. Research into microRNA molecules, specifically miR-122, has offered a potentially more sensitive alternative. One study found that serum miR-122 was elevated in dogs with chronic hepatitis even when ALT was normal, suggesting it may be a more reliable early indicator of liver injury.19PubMed Central. Evaluation of hepatocyte-derived microRNA-122 for diagnosis of acute and chronic hepatitis of dogs This test is not yet routine in general veterinary practice, but it is available through reference laboratories and could become more widely used as the evidence base grows.
Breed Predispositions and Genetic Factors
Certain breeds show up disproportionately in the bile acid conversation, and understanding breed risk helps owners and breeders make informed decisions. Maltese dogs, for instance, have a strong inherited tendency toward both extrahepatic portosystemic shunts and elevated bile acids. A study of Maltese found that the heritability of elevated post-meal bile acids, likely reflecting portal vein hypoplasia, was very high, at 0.81. The study concluded there is strong support for both extrahepatic portosystemic shunts and elevated bile acid concentrations being inherited conditions in the breed.20Wiley Online Library (Journal of Small Animal Practice). The inheritance of extra-hepatic portosystemic shunts and elevated bile acid concentrations in Maltese dogs
Yorkshire Terriers, Cairn Terriers, Pugs, and Irish Wolfhounds are also overrepresented among dogs diagnosed with portosystemic shunts. Bedlington Terriers carry a well-characterized genetic mutation for copper storage disease, and Labrador Retrievers, Dalmatians, and West Highland White Terriers are among the breeds with recognized copper accumulation problems. For breeders of affected lines, bile acid screening of breeding stock can help reduce the incidence in future generations. For owners, knowing your breed’s risk profile gives you a head start on recognizing early symptoms and pushing for the right diagnostic workup before serious damage accumulates.
The practical takeaway for anyone living with a predisposed breed is that routine bile acid screening, even in apparently healthy dogs, can catch problems before clinical signs appear. An abnormal bile acid test in a young Maltese might prompt an imaging study that identifies a shunt while the dog is still healthy enough for the best surgical outcome. In a middle-aged Labrador with no symptoms, it might lead to a liver biopsy that catches copper accumulation early enough for chelation therapy to prevent cirrhosis. The earlier you know, the more options you have.